Kangchen Pharmaceutical: Net profit in 2024 decreased by 71.94% year-on-year.

Kangchen Pharmaceuticals announced that its operating income in 2024 was 825 million yuan, a year-on-year decrease of 10.28%. The net profit attributable to shareholders of the listed company was 42.2167 million yuan, a year-on-year decrease of 71.94%. The company held its sixteenth meeting of the fourth board of directors on April 25, 2025, and approved the proposal "Regarding the 2024 Profit Distribution Plan," agreeing to distribute a cash dividend of 6 yuan for every 10 shares to shareholders who were eligible for distribution on the dividend registration date announced in the 2024 annual profit distribution plan.